If have a business interest in Human Microbiome, or looking to network with senior executives and influencers within the space, learn more about the Microbiome Congress Conference, taking place in London, UK this November 18-19, 2015.

Here’s a quick look at the Microbiome Congress Conference Day Two Agenda:

For the full speaker list with session details, download the full brochure now.

download-btn-sld

Time of Session
Type of Session
Title of Session
Session Speakers
8:30
Registration
9:00
Chairperson's Opening Remarks
9:10
Faecalibacterium Prausnitzii and Inflammatory Bowel Disease
Harry Sokol, Gastroenterology Department, Saint-Antoine Hospital, Paris, France
9:35
Track A Beta Lactamases, from Enemies to Therapies: Basis for the Development of SYN-004 Michael Kaleko, MD, PhD, Senior Vice President, Research & Development, Synthietic Biologics
9:35
Track B Regulating the Microbiome: Lessons from OpenBiome, an international public stool-bank Carolyn Edelstein, Director of Policy and Global Partnerships, OpenBiome
10:00
Track A Oral Microbiome and General Health
Egija Zaura, Associate Professor - Oral Microbial Ecology, Department of Preventative Dentistry, Academic Centre of Dentistry Amsterdam (ACTA)
10:00
Track B Fecal Microbiota Transplantation: From current practices to future therapies Mark Smith, Research Director, OpenBiome
10:25
Track A Microbiota Composition in IBS and Functional Gastrointestinal Diseases
Sasha Zhernakova, Assistant Professor, University of Groningen
Rosalind Franklin Fellowship, University of Groningen
10:25
Track B Landscape of gut microbiome in a Dutch population Jingyuan Fu, Associate Professor, Department of Pediatrics & Department of Genetics, University Medical Center Groningen
10:50
Morning Networking Break
11:20
Case Study
Towards an Affordable Diagnosis Based on Human Microbiome - Colorectal Cancer as a Case Study
Dr. Manimozhiyan Arumugam, Group Leader and Associate Professor, Novo Nordisk Foundation Centre for Metabolic Research, University of Copenhagen
11:45
Intestinal Microbiota in Metabolic Syndrome and Type 2 Diabetes: Cause or Consequence?
Max Niewdorp, Professor in Internal Medicine and Diabetes, AMC Amsterdam & Visiting Professor, Gothenborg University
12:10
Towards Population-level Microbiome Monitoring: The Flemish Gut Flora Project
Jeroen Raes, Professor - Department of Microbiology and Immunology VIB Lab for Bioinformatics and (Eco) Systems Biology, KULeuven
12:35
Networking Lunch
14:00
Track A Skin Microbiome in Health and Disease
Frank Nestle, Professor & NIHR Senior Investigator, St John's Institute of Dermatology, King's College London and Guy's & St Thomas' Hospitals
14:00
Track B Vaginal Microbiome Dysbiosis: Relevance and Treatment
Janneke van de Wijgert, Clinical Epidemiologist & Professor, Insitute of Infection and Global Health, University of Liverpool
14:35
Track A Infant Gut Microbiota and Dietary Interventions
Bernard Berger, Senior Scientist, Nestlé Research Centre in Nutrition and Health Research
14:35
Track B Modelling the Emergent Dynamics and Major Metabolites of the Human Colonic Microbiota Helen Kettle, Mathematical Modeller, Biomathematics and Statistics Scotland, Edinbrough
14:55
Microbiome research ethics and legal landscape Sequencing microbial material from humans means sequencing the human genome – ethical and regulatory considerations? Pilar N. Ossorio, Professor of Law and Bioethics, Ethics Scholar -in–Residence, Morgridge Inst. for Research, University of Wisconsin Law School
15:20
Track A Towards the 3rd Wave of Probiotic and Therapeutic Microbes
Johan E.T. van Hylckama Vlieg, Senior Director Microbiome - Health & Nutrition Division, Chr. Hansen
15:20
Track B Probiotics: from myth to molecular modes of action Patrick Veiga, Senior Scientist - Danone Nutricia Research, Life Science Department; Visiting Scientist - Harvard School of Public Health, Dept. of Immunology and Infectious Diseases, Danone Nutricia Research
15:45
Colorectal Cancer and the Gut Microbiome - Translational Applications of Gut Microbiome Research James Kinross, Senior Lecturer in Colorectal Surgery, Imperial College London
16:05
The Microbiome-Gut-Brain Axis in Autism
Ruth Ann Luna, Director, Medical Metagenomics, Texas Children’s Microbiome Center, Texas Children’s Hospital & Assistant Professor, Baylor College of Medicine
16:30
Patient engagement in Microbiome Research
Moderator: Ailsa Hart, Director IBD Unit and Sub-Dean, St Mark’s Hospital and Senior Clinical Lecturer, Department of Surgery and Cancer, Imperial College, London

Fiona Copeland, Chair - PCD Family Support Group

Alastair Kent OBE, Director of Genetic Alliance UK

Deborah Trenchard, Patient
17:10
Close of Conference

For the full speaker list with session details, download the full brochure now.

download-btn-sld